Value-Based Challenges And Opportunities For Pharma Cos.

By Eve Brunts and Alison Fethke (July 12, 2017, 1:29 PM EDT) -- Value-based health care and the high cost of drugs have both received significant attention in the ongoing debate on the future of health care. Value-based pricing for drugs may offer pharmaceutical companies an opportunity to validate the cost of their drugs and overcome obstacles to access. Over the past couple of years, pharmaceutical companies and private health plans have announced new value-based pricing arrangements linking the cost of drugs to their perceived value, receiving widespread media coverage....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!